Abstract
Patients with hormone-receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer constitute about 70% of the breas......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
